Accreditation of the PGD laboratory.

Accreditation according to an internationally recognized standard is increasingly acknowledged as the single most effective route to comprehensive laboratory quality assurance, and many countries are progressively moving towards compulsory accreditation of medical testing laboratories. The ESHRE PGD Consortium and some regulatory bodies recommend that all PGD laboratories should be accredited or working actively towards accreditation, according to the internationally recognized standard ISO 15189, 'Medical laboratories-Particular requirements for quality and competence'. ISO 15189 requires comprehensive quality assurance. Detailed management and technical requirements are defined in the two major chapters. The management requirements address quality management including the quality policy and manual, document control, non-conformities and corrective actions, continual improvement, auditing, management review, contracts, referrals and resolution of complaints. Technical requirements include personnel competence (both technical and medical), equipment, accommodation and environment, and pre-analytical, analytical and post-analytical processes. Emphasis is placed on the particular requirements of patient care: notably sample identification and traceability, test validation and interpretation and reporting of results. Quality indicators must be developed to monitor contributions to patient care and continual improvement. We discuss the implementation of ISO 15189 with a specific emphasis on the PGD laboratory, highlight elements of particular importance or difficulty and provide suggestions of effective and efficient ways to obtain accreditation. The focus is on the European environment although the principles are globally applicable.

[1]  Human Fertilisation,et al.  8th Code of Practice , 2009 .

[2]  K. Sermon,et al.  The causes of misdiagnosis and adverse outcomes in PGD. , 2009, Human reproduction.

[3]  R. Bautista-Llácer,et al.  Quality management system in PGD/PGS: now is the time , 2009, Journal of Assisted Reproduction and Genetics.

[4]  N. Muntjewerff,et al.  ESHRE PGD Consortium data collection V: cycles from January to December 2002 with pregnancy follow-up to October 2003. , 2008, Human reproduction.

[5]  J. Vanecek,et al.  Provision and quality assurance of preimplantation genetic diagnosis in Europe , 2008, European Journal of Human Genetics.

[6]  L. Gianaroli,et al.  Preimplantation genetic diagnosis (PGD), a collaborative activity of clinical genetic departments and IVF centres , 2001, Prenatal diagnosis.

[7]  C. Moutou,et al.  ESHRE PGD Consortium data collection X: cycles from January to December 2007 with pregnancy follow-up to October 2008. , 2010, Human reproduction.

[8]  C. Moutou,et al.  ESHRE PGD Consortium data collection IX: cycles from January to December 2006 with pregnancy follow-up to October 2007. , 2009, Human reproduction.

[9]  C. Moutou,et al.  ESHRE PGD Consortium data collection VIII: cycles from January to December 2005 with pregnancy follow-up to October 2006. , 2008, Human reproduction.

[10]  Guidelines for good practice in PGD: programme requirements and laboratory quality assurance. , 2008, Reproductive biomedicine online.

[11]  M. Robinson,et al.  ESHRE PGD Consortium 'Best practice guidelines for clinical preimplantation genetic diagnosis (PGD) and preimplantation genetic screening (PGS)'. , 2005, Human reproduction.

[12]  Dutch-speaking Brussels ESHRE PGD Consortium 'Best practice guidelines for clinical preimplantation genetic diagnosis (PGD) and preimplantation genetic screening (PGS)' , 2004 .